Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.


Product Name:                  5-Nitrocyclohexene-1-carbaldehyde

Synonyms:                         N/A

CAS Number:                     900186-75-6

Molecular Weight:            155.153

Molecular Formula:          C7H9NO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=[N+]([O-])C1CCC=C(C=O)C1

  • $700.00
  • Ex Tax: $700.00

Available Options